Table of Contents Table of Contents
Previous Page  758-759 / 1173 Next Page
Information
Show Menu
Previous Page 758-759 / 1173 Next Page
Page Background

ESTRO

Radio-enhancement by dFdC of a human squamous

cell carcinoma cell line (SQD9)

10 -4

10

-3

10

-2

10 -1

10

0

0

2

4

6

8

10

12

14

Rx alone

dFdC (5 µM) for

3 h prior to Rx

Surviving Fraction

Absorbed dose (Gy)

DMF=1.3

DMF=1.3

DMF=1.3

(Gy

-1

) (Gy

-2

)

Rx

0.30 0.02

Rx + dFdC 0.38 0.04